Lexston Life Sciences Corp. Statistics
Want to see TSE:LEXT full AI Analyst Report?
Lexston Life Sciences Corp. (LEXT) Stock Statistics & Valuation Metrics
Total Valuation
Lexston Life Sciences Corp. has a market cap or net worth of CAD 1.05M. The enterprise value is CAD 2.01M.
- Market Cap
- CAD 1.05M
- Enterprise Value
- CAD 2.01M
Share Statistics
Lexston Life Sciences Corp. has 26,238,218 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 26,238,218
- Owned by Insiders
- ―
- Owned by Institutions
- 0.02%
Financial Efficiency
Lexston Life Sciences Corp.’s return on equity (ROE) is -1.92 and return on invested capital (ROIC) is -182.49%.
- Return on Equity (ROE)
- -1.92
- Return on Assets (ROA)
- -1.60
- Return on Invested Capital (ROIC)
- -182.49%
- Return on Capital Employed (ROCE)
- -1.82
- Revenue Per Employee
- ―
- Profits Per Employee
- ―
- Employee Count
- 0
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Lexston Life Sciences Corp. is -0.59. Lexston Life Sciences Corp.’s PEG ratio is -0.00.
- PE Ratio
- -0.59
- PS Ratio
- 0.00
- PB Ratio
- 1.87
- Price to FCF
- -0.86
- Price to Operating Cash Flow
- -0.93
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Lexston Life Sciences Corp. had revenue of 0 and earned -1.42M in profits. Earnings per share was -0.08.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -1.35M
- Pretax Income
- -1.35M
- Net Income
- -1.42M
- EBITDA
- -1.35M
- Earnings Per Share (EPS)
- -0.08
Cash Flow
In the last 12 months, operating cash flow was -1.09M and capital expenditures -3, giving a free cash flow of -1.09M billion.
- Operating Cash Flow
- -1.09M
- Free Cash Flow
- -1.09M
- Free Cash Flow per Share
- -0.04
Dividends & Yields
Lexston Life Sciences Corp. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -116.77%
- Earnings Yield
- -137.29%
Stock Price Statistics
- Beta
- 0.28
- 52-Week Price Change
- -84.62%
- 50-Day Moving Average
- 0.05
- 200-Day Moving Average
- 0.07
- Relative Strength Index (RSI)
- 41.93
- Average Volume (3m)
- 40.94K
Important Dates
Lexston Life Sciences Corp. upcoming earnings date is Jan 06, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 14, 2026
- Next Earnings Date
- Jan 06, 2027
- Ex-Dividend Date
- ―
Financial Position
Lexston Life Sciences Corp. as a current ratio of 1.96, with Debt / Equity ratio of 0.00%
- Current Ratio
- 1.96
- Quick Ratio
- 1.96
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.09
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Lexston Life Sciences Corp. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Lexston Life Sciences Corp. EV to EBITDA ratio is -0.69, with an EV/FCF ratio of -0.85.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.69
- EV to Free Cash Flow
- -0.85
- EV to Operating Cash Flow
- -0.85
Balance Sheet
Lexston Life Sciences Corp. has CAD 6,570.00 in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of CAD 6,570.00 billion.
- Cash & Marketable Securities
- CAD 6,570.00
- Total Debt
- CAD 0.00
- Net Cash
- CAD 6,570.00
- Net Cash Per Share
- CAD 0.00
- Tangible Book Value Per Share
- CAD 0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Lexston Life Sciences Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 71.78%
Scores
- Smart Score
- ―
- AI Score
- 40
